Price Target Update on CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) : Currently there are 22 street experts covering CVS Health Corporation (NYSE:CVS) stock. The most bullish and bearish price target for the stock is $123 and $90 respectively for the short term. The average price target of all the analysts comes to $112.3. The estimated standard deviation from the target is $7.94.

Other Equity analysts have also commented on the company shares. Jefferies maintains their rating on the shares of CVS Health Corporation (NYSE:CVS). The current rating of the shares is Buy. Equity Analysts at the Firm raises the price target to $122 per share from $110 per share. The rating by the firm was issued on May 12, 2016.

CVS Health Corporation (NYSE:CVS): stock turned positive on Thursday. Though the stock opened at $94.44, the bulls momentum made the stock top out at $94.49 level for the day. The stock recorded a low of $93.44 and closed the trading day at $94.02, in the green by 0.31%. The total traded volume for the day was 3,862,683. The stock had closed at $93.73 in the previous days trading.

The company shares have dropped -10.74% from its 1 Year high price. On Jul 29, 2015, the shares registered one year high at $113.65 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $98.95 and the 200 Day Moving Average price is recorded at $98.39. On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (President and CEO) of Cvs Health Corp, Merlo Larry J had sold 38,247 shares worth of $4,015,935 in a transaction dated May 5, 2016. In this transaction, 38,247 shares were sold at $105 per share.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.